The spiroindolones are an emerging class of antimalarial drugs whose mode of action is to inhibit protein synthesis in the target parasite. In the September 2010 edition of Science, Rottmann et al. reported the development of a successful anti-malarial spiroindolone: NITD609.
References
Spiroindolone Wikipedia(Text) CC BY-SA